AGN-210961
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AGN-210961, covering 2014-08-05 to 2014-08-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension [Phase 2]